Diagonal Therapeutics
Diagonal Therapeutics is a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases. From its funding announcement.
In their own words
What Diagonal Therapeutics says it is doing
Public signal Described in the funding announcement as "biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases". Source
Public signal Read from the company's own description of what the funding supports.
Why now
Where Diagonal Therapeutics is today
Diagonal Therapeutics announced a Series B round of $125M on 9 January 2026.
Momentum AfterRaise intelligence
AfterRaise Score
- Hiring momentum Open roles and hiring pace
- Market expansion New offices and new countries
- Leadership Executive appointments
- Product activity Launches and releases
Since the raise
What has happened since
- 9 January 2026$125M Series BInvestors not stated in the announcement.
Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.
What may happen next
What this raise could create
What may happen next
- Regulatory and certification milestones
- Compliance team growth
- Aggressive multi-front expansion
- Senior executive hiring
Opportunities this could create
- Regulatory affairs
- Quality systems
- Scientific hiring
- Regulatory advisers
- Certification specialists
Based on the Biotech & Pharma sector, a Series B round and the priorities the company itself set out. Not a statement of fact.
- 9 January 2026$125M Series B announced
- 9 January 2026Stated priority: regulatory
High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.
Open to
What Diagonal Therapeutics is open to
Not yet specified
Diagonal Therapeutics has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.
Work here? Set your preferencesOpportunities
Ways to work with Diagonal Therapeutics
No open opportunities listed
Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.
Work here? Open the first oneHelpful contributors
People who have contributed here
Nobody yet
When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.
Do you work at Diagonal Therapeutics?
Claim your company profile.
This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.
What we do not have yet: your website, the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.
Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.
Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.
Also moving